文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
S. Yin
发表
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
R. Stocco, A. Roulston, Jordan T. F. Young, 2021, Molecular Cancer Therapeutics.